Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information

Trial N/A Completed June 14, 2026

At-home taVNS for Neurorehabilitation in Parkinson's Disease

Trial N/A Recruiting June 14, 2026

Prospective Multicenter Registry Study of Multiple System Atrophy in China

Trial N/A Recruiting June 11, 2026

Evaluation of Clinical Perfectionism in Parkinson Disease

Trial N/A Completed June 11, 2026

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease

Trial Phase 2 Completed June 11, 2026

Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment

Trial N/A Recruiting June 11, 2026

Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease

Trial N/A Not yet recruiting June 11, 2026

Neurophysiology of Reward Signaling in Parkinson's Disease

Trial N/A Recruiting June 11, 2026

Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders

Trial Phase 3 Terminated June 11, 2026

The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy

Trial N/A Active, not recruiting June 10, 2026

Effect of Training and Use of Cane on Gait in Individuals With Parkinson's Disease

Trial N/A Recruiting June 10, 2026

Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease

Trial Phase 4 Not yet recruiting June 10, 2026

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

Trial N/A Recruiting June 10, 2026

Telerehabilitation Versus Face-to-Face LSVT BIG in Individuals With Parkinson Disease

Trial N/A Not yet recruiting June 10, 2026

An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease

Trial Phase 1 Active, not recruiting June 10, 2026

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Trial Phase 2 Completed June 9, 2026

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

Trial Early Phase 1 Recruiting June 9, 2026

Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients

Trial N/A Not yet recruiting June 9, 2026

Characterization of the Involvement of the Subthalamic Nucleus During Wakefulness and Sleep in Parkinson's Disease: Contribution of Deep Brain Stimulation

Trial N/A Not yet recruiting June 9, 2026

Upper Extremity Skills, Trunk Control, and Body Awareness in Parkinson's Disease

Trial N/A Not yet recruiting June 9, 2026